NYSEMKT: CANFCan Fite Biopharma Ltd Stock Ownership - Who owns Can Fite Biopharma?
Insider buying vs selling
Have Can Fite Biopharma Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CANF insiders and whales buy or sell their stock.
CANF Shareholders
What type of owners hold Can Fite Biopharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sabby Management LLC | 0.02% | 779,744 | $327.49k | Institution |
| Rhumbline Advisers | 0.00% | 57,582 | $24.18k | Institution |
| Bnp Paribas Financial Markets | 0.00% | 17,585 | $7.39k | Institution |
| Two Sigma Securities LLC | 0.00% | 16,064 | $6.75k | Institution |
| Captrust Financial Advisors | 0.00% | 11,375 | $4.78k | Institution |
| Morgan Stanley | 0.00% | 9,912 | $4.16k | Institution |
| Ubs Group Ag | 0.00% | 5,515 | $2.32k | Institution |
| Fifth Third Bancorp | 0.00% | 3,000 | $1.26k | Institution |
| Wells Fargo Company | 0.00% | 2,700 | $1.13k | Institution |
| Costello Asset Management Inc | 0.00% | 1,000 | $420.00 | Institution |
CANF vs Biotech Stocks
Can Fite Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.